ESC Premium Access

Outcomes associated with respiratory failure for patients with cardiogenic shock and acute myocardial infarction: a substudy of the culprit-shock trial

Congress Session

About the speaker

Associate Professor Maria Rubini Gimenez

Heart Center of Leipzig, Leipzig (Germany)
11 presentations
1 follower

7 more presentations in this session

The in-hospital outcomes of the use of microaxial left ventricular assist device vs intra-aortic ballon pump in acute myocardial infarction complicated by cardiogenic shock.

Speaker: Doctor Y. Yang (Valhalla, US)

Thumbnail

Combined use of VA-ECMO and IMPELLA (ECPELLA) as a possible strategy to improve outcomes in patients who underwent E-CPR

Speaker: Doctor T. Unoki (Kumamoto, JP)

Thumbnail

Impact of door-to-deployment time of venoarterial extracorporeal membrane oxygenation for out-of-hospital refractory cardiac arrest patients secondary to cardiovascular causes

Speaker: Mr H. Muranishi (Takatsuki, JP)

Thumbnail

Left heart Impella-device to bridge acute mitral regurgitation to MitraClip-procedure: a novel implementation of percutaneous mechanical circulatory support

Speaker: Doctor C. Vandenbriele (Leuven, BE)

Thumbnail

Use of extracorporeal membrane oxygenation in acute pulmonary embolism: a pooled analysis

Speaker: Doctor L. Baldetti (Milan, IT)

Thumbnail

Access the full session

Mechanic and Ventilatory Support, and Cardiogenic Shock

Speakers: Associate Professor M. Rubini Gimenez, Doctor Y. Yang, Doctor T. Unoki, Mr H. Muranishi, Doctor C. Vandenbriele...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

ESC Premium Access

Mechanical support devices in STEMI and shock: when and in whom?

30 August 2021

ESC Premium Access

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy

29 August 2021

ESC Premium Access

Prognostic value of fractional flow reserve using computed tomography for predicting major adverse cardiac events and mortality in kidney transplant candidates

29 August 2021

This platform is supported by

logo Novo Nordisk